Sarepta Therapeutics, Inc.
Neuromuscular-focused biotech with approved Duchenne gene and exon-skipping therapies plus additional gene-therapy programs.
Neuromuscular rare disease · AAV gene therapy & exon-skipping oligonucleotides · Commercial + clinical